| abstract |
Provided herein are methods that use liver targeting domains of colon cancer, such as for example PA28alpha, HNRNPAl, and/or KIAA1407, and the polynucleotides that encode them, for the prognosis, diagnosis, detection, staging and/or prediction of survival rates in individuals with colon cancer, whether the cancer has metastasized or not, as well as for imaging purposes and design of diagnostic and/or therapeutic methods. |